NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Float Percentage Of Total Shares Outstanding : 59.09% (As of May. 25, 2024)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's float shares is 53.18 Mil. NewAmsterdam Pharma Co NV's total shares outstanding is 89.99 Mil. NewAmsterdam Pharma Co NV's float percentage of total shares outstanding is 59.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's Insider Ownership is 0.25%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NewAmsterdam Pharma Co NV's Institutional Ownership is 4.03%.

NewAmsterdam Pharma Co NV Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

NewAmsterdam Pharma Co NV's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	53.18	/	89.99
	=	59.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.